FDA FAERS Reports for Treprostinil (TYVASO DPI) from Jan 1, 2024 to Mar 3, 2025

FDA FAERS Reports for Treprostinil (TYVASO DPI) from Jan 1, 2024 to Mar 3, 2025

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: All FDA FAERS reports for treprostinil (brand name TYVASO DPI) from January 1 2024 to March 3 2025.
Tags: Pharma, FAERS, 2024
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

View full details